๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

635 A study of SRL 172 (mycobacterium vaccae) as the first component of a tumour vaccine with immunological changes and clinical activity in patients with lung cancer

โœ Scribed by O'Brien, M.E.R.; Bromelow, K.; Prendiville, J.; Rees, C.; Hill, M.; Stanford, J.; Grange, J.; Farzaneh, F.; Smith, I.E.; Souberbielle, B.E.


Book ID
123126831
Publisher
Elsevier Science
Year
1997
Tongue
English
Weight
148 KB
Volume
18
Category
Article
ISSN
0169-5002

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Phase II study of pemetrexed disodium, a
โœ Frances A. Shepherd; Janet Dancey; Andrew Arnold; Alan Neville; James Rusthoven; ๐Ÿ“‚ Article ๐Ÿ“… 2001 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 90 KB ๐Ÿ‘ 3 views

## Background: Pemetrexed disodium (alimta [eli lilly and company, indianapolis, in], ly231514, multitargeted antifolate) is a new multitargeted antifolate agent that inhibits multiple enzymes in the folate pathway. phase ii trials showed single-agent response rates of 16% and 23% in untreated pati